Header Logo

Connection

Simiso Sokhela to HIV Integrase Inhibitors

Back to Details
This is a "connection" page, showing publications Simiso Sokhela has written about HIV Integrase Inhibitors.
Simiso Sokhela
Connection Strength
0,266
HIV Integrase Inhibitors
  1. Time to rethink endpoints for new clinical trials of antiretrovirals? Long-term re-suppression of HIV RNA with integrase inhibitors. AIDS. 2020 02 01; 34(2):321-324.
    View in: PubMed
    Score: 0,169
  2. Determinants of early change in serum creatinine after initiation of dolutegravir-based antiretroviral therapy in South Africa. Br J Clin Pharmacol. 2024 May; 90(5):1247-1257.
    View in: PubMed
    Score: 0,056
  3. Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV. N Engl J Med. 2019 08 29; 381(9):803-815.
    View in: PubMed
    Score: 0,041
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.